How Big Pharma hurt biotech; EMA's CHMP gives nod to GSK vax;

Tools

@FierceBiotech: Humans to test T-cell treatment that subdued canine lymphoma. More | Follow @FierceBiotech

@JohnCFierce: You gotta love the hep C arena right now. $VRTX up, $IDIX down, $GILD wounded. Like 3-D chess: One bad or good move changes the whole game. | Follow @JohnCFierce

@RyanMFierce: As one might expect, more good questions than good answers on the $GILD call this A.M. | Follow @RyanMFierce

@FierceMedDev: Profits at Medtronic down 21%. Article via @the_irish_times | Follow @FierceMedDev

> Forbes contributor Avik Roy explains how Big Pharma is to blame for biotech companies' inability to bring drugs to market without a partnership. Article

> The European Medicines Agency’s CHMP has given a nod to GlaxoSmithKline’s ($GSK) meningitis vaccine Nimenrix, recommending approval in the EU. Report 

> Alexza Pharmaceuticals ($ALXA), a Mountain View, CA-based developer of pain drugs, said today that it has priced a public offering to raise $22 million. Release

Pharma News

@FiercePharma: Risperdal didn't cause one man's diabetes, but J&J didn't do enough to warn his doctor, jury finds--Bloomberg. Story | Follow @FiercePharma

> AZ sells discounted cancer drug directly to patients. News

> Finding study flaws, EMA backpedals on Trasylol suspension. Story

> J&J pulls infant Tylenol on dosing-system issue. More

And Finally… DNA robots could be enlisted to search and attack diseases. Article